Study: Patients Replace Prescription Drugs With Cannabis

45
Patients with legal access to medical marijuana reduce their consumption of conventional pharmaceuticals, according to a demographic review of patient characteristics published online in the Journal of Psychoactive Drugs.Investigators affiliated with the Medical Marijuana Research Institute in Mesa surveyed responses from 367 state-qualified patients recruited from four Arizona medical cannabis dispensaries. Respondents were more likely to be male, in their mid-40s, and daily consumers of cannabis.

Respondents most often reported using cannabis therapeutically to treat symptoms of chronic pain, muscle spasms, nausea, anxiety, arthritis, depression, headaches, insomnia, and stress. Patients typically said that cannabis provided “a lot of relief” or “almost complete relief” of their symptoms and that its efficacy was greater than that of more conventional medications.

Patients also reported reducing their use of pharmaceuticals. Over 70 percent of respondents reported using other medications “a little less frequently” or “much less frequently” for 24 of the 42 conditions specified. Over 90 percent of those who reported consuming cannabis to mitigate symptoms of nausea, headache, muscle spasms, fibromyalgia, bowel distress, and chronic pain acknowledged using pharmaceuticals less frequently once they had initiated cannabis therapy.

Previously published survey data of medical cannabis patients similarly reportsubjects’ willingness to substitute cannabis for prescription drugs, particularly opioids.

A study published in July by the National Bureau of Economic Research, a non-partisan think-tank, reported, “tates permitting medical marijuana dispensaries experience a relative decrease in both opioid addictions and opioid overdose deaths compared to states that do not.” Data published in 2014 in the Journal of the American Medical Association (JAMA) Internal Medicine similarly reported, “States with medical cannabis laws had a 24.8 percent lower mean annual opioid overdose mortality rate compared with states without medical cannabis laws.”

Full text of the study, “Medical cannabis in Arizona: Patient characteristics, perceptions, and impressions of medical cannabis legalization,” appears in the Journal of Psychoactive Drugs.

Paul Armentano is the Deputy Director of NORML, an organization that advocates for legalization and the responsible use of marijuana.

SHARE
Previous articleFrom Colds To Cancer, How Sage Is Essential To Health
Next articleHow Fast Does Cancer Grow? Do Your Choices Have An Impact?
CEO & Founder at Psychedelic Society and www.sociedelic.com. I created this community in 2013 shortly after finishing high school and have been grateful for the fact that I have been able to do this ever since :) There are many things happening on the planet that don't resonate with me, and I wanted to do what I could to play a role in creating change. It's been great making changes in my own life and creating awareness and I look forward to more projects that move beyond awareness and into action and implementation. So stay tuned :)